Hsbc Holdings »

Adaptimmune Therapeutics shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $19k 27k 0.71
2023-09-30 $20k 26k 0.77
2023-06-30 $24k 26k 0.92